{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a117a48a\"></iframe>","width":"100%","height":180,"duration":553,"description":"Loralie Langman, Ph.D., and Paul Jannetto, Ph.D., discuss Mayo Clinic Laboratories' new addiction rehabilitation monitoring profile, a comprehensive evaluation to help guide and monitor patients as part of their treatment and recovery. Geared toward managing patients with addiction to common substances, the profile tests for opioids, benzodiazepines, stimulants, barbiturates, cocaine, marijuana, ethanol, and nicotine. The inclusion of specimen validity testing and enhanced reports with interpretive comments enables a clear picture of a patient’s substance use.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}